Molecule V2 establishes a blockchain protocol for the tokenization of scientific intellectual property (IP). This framework converts research outputs—including datasets and patents—into liquid digital assets.
The architecture utilizes an oracle network for metadata submission, while zero-knowledge proofs (ZKPs) verify IP validity without requiring premature disclosure. Assets are minted on a layer-2 chain and secured via IPFS for immutable storage.
Smart contracts automate royalty distribution and licensing, replacing manual legal processes. Governance is centralized within a DAO, where stakeholders vote on commercialization and strategic collaborations.
Beta tests involving neuroscience datasets achieved a 4x increase in liquidity over traditional VC models. Licensing times were reduced by 65%, with pilot DAOs deploying $1.2M in grants.
This protocol transforms research into a tradable asset class, enabling decentralized funding and rapid global collaboration.